QURE
uniQure N.V.#33 · 2019EPAYearly return
+151%
Peak return
+189%
Max drawdown
-56%
ADR (20 days)
+5.4%
Base
22 days / -27.3%
Prior run
+89%
Breakout volume
10.9x
Pivot
$41.61
Catalyst FDA/Clinical2019-02-262 More Gene Therapy Stocks on Big Pharma's Buyout RadarThe Motley Fool
Biotech-/Medtech-News mit binaerem Daten-, Zulassungs- oder Studiencharakter.
Healthcare · Healthcare & Biotech
Continue in the full Atlas
Drawing, alerts, replay and the live scanner built on the same criteria are part of WickedDesk. Compare QURE with the current market directly.